These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 4151048

  • 1. Antiarrhythmic and general cardiovascular activity of the N,N-dimethylquaternary ammonium derivative of bunolol.
    Kaplan HR, Barker JW, Dugan D, Fox J, Giardino E.
    Arch Int Pharmacodyn Ther; 1974 Jan; 207(1):28-43. PubMed ID: 4151048
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cardiovascular actions of a new metabolite of propranolol: isopropylamine.
    Ishizaki T, Privitera PJ, Walle T, Gaffney TE.
    J Pharmacol Exp Ther; 1974 Jun; 189(3):626-32. PubMed ID: 4152314
    [No Abstract] [Full Text] [Related]

  • 4. Elevation of ventricular fibrillatory threshold by beta-adrenergic blocking agents.
    Baum T, Peters JR, Eckfeld DK, Varner LL, Dinish J, Metz N, Shropshire AT.
    Arch Int Pharmacodyn Ther; 1972 Dec; 200(2):292-300. PubMed ID: 4405153
    [No Abstract] [Full Text] [Related]

  • 5. The antiarrhythmic and cardiovascular properties of 1-dimethyl isopropylamino-3-(2-phenylphenoxy)-propan-2-ol chloride, UM-424.
    Kniffen FJ, Winokur S, Counsell RE, Lucchesi BR.
    J Pharmacol Exp Ther; 1976 Feb; 196(2):420-32. PubMed ID: 3643
    [Abstract] [Full Text] [Related]

  • 6. N-n-propyl-ajmaline-bitartrate (NPAB), a new antiarrhythmic drug. Comparative studies on the antifibrillatory and hemodynamic effects in the anaesthetised cat.
    Diederich KW, Boyksen D.
    Arzneimittelforschung; 1973 Sep; 23(9):1302-5. PubMed ID: 4801225
    [No Abstract] [Full Text] [Related]

  • 7. The antiarrhythmic properties of UM-272, the dimethyl quaternary derivative of propranolol.
    Schuster DP, Lucchesi BR, Nobel NL, Mimnaugh MN, Counsell RE, Kniffen FJ.
    J Pharmacol Exp Ther; 1973 Jan; 184(1):213-27. PubMed ID: 4405548
    [No Abstract] [Full Text] [Related]

  • 8. Derivatives of 3,4-dihydro-1(2H)-naphthalenone as beta-adrenergic blocking agents. 2. Aromatic-substituted analogs of bunolol.
    Schwender CF, Pike RE, Shavel J.
    J Med Chem; 1973 Mar; 16(3):254-7. PubMed ID: 4147388
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of B.W. 62-235 and lidocaine with respect to cardiovascular, anti-arrhythmic and local anesthetic actions.
    Paradise RR, Stoelting VK.
    Arch Int Pharmacodyn Ther; 1966 May; 161(1):17-29. PubMed ID: 4380176
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Some cardiovascular effects of timolol a new beta-adrenergic blocking agent.
    Scriabine A, Torchiana ML, Stavorski JM, Ludden CT, Minsker DH, Stone CA.
    Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):76-93. PubMed ID: 4148410
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Beta receptor blocking and antiarrhythmic properties of tolamolol.
    Bagwell EE, Custy J, Steen RG, Newman WH.
    J Pharmacol Exp Ther; 1974 Dec; 191(3):496-505. PubMed ID: 4154378
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Relative beta adrenergic receptor blocking activity in dogs after intravenous and intraportal vein administration: bunolol, propranolol, their levo isomers and sotalol.
    Kaplan HR, Commarato MA.
    J Pharmacol Exp Ther; 1973 May; 185(2):395-405. PubMed ID: 4145046
    [No Abstract] [Full Text] [Related]

  • 16. Antagonism of cardiac arrhythmias by beta-adrenoreceptor blocking agents.
    Laddu AR, Kumakura S, Somani P.
    Arch Int Pharmacodyn Ther; 1972 Nov; 200(1):168-81. PubMed ID: 4404932
    [No Abstract] [Full Text] [Related]

  • 17. Role of vagus in the antagonism of ouabain induced arrhythmias in dogs by beta-adrenoceptor antagonists and related drugs.
    Alkondon M, Ray A, Sen P.
    J Pharm Pharmacol; 1984 Oct; 36(10):702-4. PubMed ID: 6150094
    [Abstract] [Full Text] [Related]

  • 18. CL-845 (pirmenol hydrochloride): a new orally effective long-acting antiarrhythmic agent.
    Steffe TJ, Mertz TE, Hastings SG, Potoczak RE, Kaplan HR.
    J Pharmacol Exp Ther; 1980 Jul; 214(1):50-7. PubMed ID: 7391970
    [No Abstract] [Full Text] [Related]

  • 19. Cardiovascular effects of a newer antiarrhythmic agent, disopyramide phosphate.
    Mathur PP.
    Am Heart J; 1972 Dec; 84(6):764-70. PubMed ID: 4150336
    [No Abstract] [Full Text] [Related]

  • 20. [Arrhythmia action and cardiovascular effects of a new beta-adrenergic blockader (Oxprenolol)].
    Suzuki K, Kubota M, Odashiro M, Yasuda K, Goto Y.
    Masui; 1972 Jan; 21(1):46-50. PubMed ID: 4401935
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.